BeyondSpring Inc. (BYSI) is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. The company's pipeline includes plinabulin, a novel anticancer agent being developed for multiple oncology indications. BeyondSpring conducts clinical trials and research aimed at bringing new treatments to patients with unmet medical needs in oncology.
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | BYSI | discussed_in_filing Cybersecurity | |
| topic_mention | BYSI | discussed_in_filing Trusted Computing | |
| topic_mention | BYSI | discussed_in_filing Blockchain & Crypto | |
| topic_mention | BYSI | discussed_in_filing Capital Expenditure | |
| topic_mention | BYSI | discussed_in_filing Regulation | |
| topic_mention | BYSI | discussed_in_filing Healthcare & Bio | |
| topic_mention | BYSI | discussed_in_filing Platform & Ecosystem | |
| topic_mention | BYSI | discussed_in_filing Sovereign & Government | |
| topic_mention | BYSI | discussed_in_filing Cybersecurity | |
| topic_mention | BYSI | discussed_in_filing Trusted Computing | |
| topic_mention | BYSI | discussed_in_filing Blockchain & Crypto | |
| topic_mention | BYSI | discussed_in_filing Capital Expenditure | |
| topic_mention | BYSI | discussed_in_filing Regulation | |
| topic_mention | BYSI | discussed_in_filing Healthcare & Bio | |
| topic_mention | BYSI | discussed_in_filing Platform & Ecosystem | |
| topic_mention | BYSI | discussed_in_filing Sovereign & Government | |
| topic_mention | BYSI | discussed_in_filing Cybersecurity | |
| topic_mention | BYSI | discussed_in_filing Trusted Computing | |
| topic_mention | BYSI | discussed_in_filing Blockchain & Crypto | |
| topic_mention | BYSI | discussed_in_filing Capital Expenditure | |
This is the free public profile. For structured JSON with full provenance chain, use the API: